These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

107 related articles for article (PubMed ID: 5107435)

  • 21. Prognosis in patients with atrial fibrillation and CHA2DS2-VASc Score = 0 in a community-based cohort study.
    Taillandier S; Olesen JB; Clémenty N; Lagrenade I; Babuty D; Lip GY; Fauchier L
    J Cardiovasc Electrophysiol; 2012 Jul; 23(7):708-13. PubMed ID: 22268375
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Lasting anticoagulant prevention following myocardial infarct].
    Remde W
    Z Gesamte Inn Med; 1968 Mar; 23(6):85-8. PubMed ID: 5727299
    [No Abstract]   [Full Text] [Related]  

  • 23. [Self-monitoring of the effect from indirect anticoagulant agents allows for the decrease of overall mortality, incidence of thromboembolic and hemorrhagic complications].
    Iavelov IS
    Kardiologiia; 2006; 46(4):62. PubMed ID: 16710207
    [No Abstract]   [Full Text] [Related]  

  • 24. D-dimer testing to select patients with a first unprovoked venous thromboembolism who can stop anticoagulant therapy: a cohort study.
    Kearon C; Spencer FA; O'Keeffe D; Parpia S; Schulman S; Baglin T; Stevens SM; Kaatz S; Bauer KA; Douketis JD; Lentz SR; Kessler CM; Moll S; Connors JM; Ginsberg JS; Spadafora L; Julian JA;
    Ann Intern Med; 2015 Jan; 162(1):27-34. PubMed ID: 25560712
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Determining the risk of bleeding in warfarin therapy.
    Ebell MH
    J Fam Pract; 1999 Jun; 48(6):413. PubMed ID: 10386476
    [No Abstract]   [Full Text] [Related]  

  • 26. Recurrent thromboembolism in cancer patients: incidence and risk factors.
    Prandoni P; Piccioli A; Pagnan A
    Semin Thromb Hemost; 2003 Dec; 29 Suppl 1():3-8. PubMed ID: 14730471
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Anticoagulant therapy and hemorrhagic accidents].
    Hachen HJ
    Rev Med Suisse Romande; 1968 Jun; 88(6):406-12. PubMed ID: 5740814
    [No Abstract]   [Full Text] [Related]  

  • 28. [Treatment of bleeding in patients undergoing oral anticoagulant therapy].
    Riess H
    Klin Monbl Augenheilkd; 2014 Apr; 231(4):e23-34; quiz e35-6. PubMed ID: 24771193
    [No Abstract]   [Full Text] [Related]  

  • 29. A method to determine the optimal intensity of oral anticoagulant therapy.
    Rosendaal FR; Cannegieter SC; van der Meer FJ; Briët E
    Thromb Haemost; 1993 Mar; 69(3):236-9. PubMed ID: 8470047
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Anticoagulant treatment and digestive hemorrhages].
    Himbert J; Sée E; Thiroloix P; Lenègre J
    Ann Med Interne (Paris); 1971 Nov; 122(11):1055-64. PubMed ID: 5317109
    [No Abstract]   [Full Text] [Related]  

  • 31. Extended anticoagulation for a first episode of idiopathic venous thromboembolism.
    Sparano N; English R
    J Fam Pract; 1999 Aug; 48(8):579-80. PubMed ID: 10496632
    [No Abstract]   [Full Text] [Related]  

  • 32. Use of anticoagulants in elderly patients.
    Bauersachs RM
    Thromb Res; 2012 Feb; 129(2):107-15. PubMed ID: 22014849
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Perioperative control of vitamin K antagonists in elective surgery].
    Revigliono JI; Cornavaca T; Becerra F; Albertini R; Contreras AE; Tabares A
    Medicina (B Aires); 2014; 74(5):385-90. PubMed ID: 25347900
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Risk of falls and major bleeds in patients on oral anticoagulation therapy.
    Donzé J; Clair C; Hug B; Rodondi N; Waeber G; Cornuz J; Aujesky D
    Am J Med; 2012 Aug; 125(8):773-8. PubMed ID: 22840664
    [TBL] [Abstract][Full Text] [Related]  

  • 35. High complication and failure rates of anticoagulant therapy are avoidable.
    Broekmans AW; Loeliger EA
    Z Kardiol; 1986; 75 Suppl 2():298-301. PubMed ID: 3727706
    [No Abstract]   [Full Text] [Related]  

  • 36. Twelve-month outcomes and predictors of very stable INR control in prevalent warfarin users.
    Witt DM; Delate T; Clark NP; Martell C; Tran T; Crowther MA; Garcia DA; Ageno W; Hylek EM;
    J Thromb Haemost; 2010 Apr; 8(4):744-9. PubMed ID: 20398186
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Dental extractions in patients taking anticoagulants: is alteration of the anticoagulant regime necessary?].
    Madrid C
    Rev Med Suisse; 2005 May; 1(21):1418, 1421-2, 1424. PubMed ID: 15997980
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Optimum duration of anticoagulant treatment after an episode of venous thromboembolism].
    Couturaud F; Kearon C
    Rev Pneumol Clin; 2008 Dec; 64(6):305-15. PubMed ID: 19084210
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Recommended use of INR in the laboratory monitoring of oral anticoagulant treatment].
    Syrjälä M
    Duodecim; 1998; 114(6):573-5. PubMed ID: 11466922
    [No Abstract]   [Full Text] [Related]  

  • 40. [Anticoagulant therapy in geriatrics].
    Koller F
    G Gerontol; 1968 Oct; 16(10):1161-71. PubMed ID: 5734770
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.